Dr Reddy’s launches generic version of Vimovo

Our Bureau Hyderabad | Updated on February 27, 2020

Dr Reddy’s Laboratories Ltd has announced the first-to-market launch of naproxen and esomeprazole magnesium delayed-release tablets. They are the therapeutic equivalent generic version of Vimovo, approved by the US Food and Drug Administration (USFDA).

“This launch is a testament to our core strengths in the areas of research and development and intellectual property,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy’s, said in a release. “We are excited to be a part of forming the first generic market for Vimovo tablets and to provide an affordable treatment alternative for patients.”

The Vimovo brand had US sales of approximately $414 million for the 12 months ended December 2019, according to IQVIA Health.

Published on February 27, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like